Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

Proteomics, Post-translational Modifications, and Integrative Analyses Reveal Molecular Heterogeneity within Medulloblastoma Subgroups.

Archer TC, Ehrenberger T, Mundt F, Gold MP, Krug K, Mah CK, Mahoney EL, Daniel CJ, LeNail A, Ramamoorthy D, Mertins P, Mani DR, Zhang H, Gillette MA, Clauser K, Noble M, Tang LC, Pierre-François J, Silterra J, Jensen J, Tamayo P, Korshunov A, Pfister SM, Kool M, Northcott PA, Sears RC, Lipton JO, Carr SA, Mesirov JP, Pomeroy SL, Fraenkel E.

Cancer Cell. 2018 Sep 10;34(3):396-410.e8. doi: 10.1016/j.ccell.2018.08.004.

PMID:
30205044
2.

Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohort.

Waszak SM, Northcott PA, Buchhalter I, Robinson GW, Sutter C, Groebner S, Grund KB, Brugières L, Jones DTW, Pajtler KW, Morrissy AS, Kool M, Sturm D, Chavez L, Ernst A, Brabetz S, Hain M, Zichner T, Segura-Wang M, Weischenfeldt J, Rausch T, Mardin BR, Zhou X, Baciu C, Lawerenz C, Chan JA, Varlet P, Guerrini-Rousseau L, Fults DW, Grajkowska W, Hauser P, Jabado N, Ra YS, Zitterbart K, Shringarpure SS, De La Vega FM, Bustamante CD, Ng HK, Perry A, MacDonald TJ, Hernáiz Driever P, Bendel AE, Bowers DC, McCowage G, Chintagumpala MM, Cohn R, Hassall T, Fleischhack G, Eggen T, Wesenberg F, Feychting M, Lannering B, Schüz J, Johansen C, Andersen TV, Röösli M, Kuehni CE, Grotzer M, Kjaerheim K, Monoranu CM, Archer TC, Duke E, Pomeroy SL, Shelagh R, Frank S, Sumerauer D, Scheurlen W, Ryzhova MV, Milde T, Kratz CP, Samuel D, Zhang J, Solomon DA, Marra M, Eils R, Bartram CR, von Hoff K, Rutkowski S, Ramaswamy V, Gilbertson RJ, Korshunov A, Taylor MD, Lichter P, Malkin D, Gajjar A, Korbel JO, Pfister SM.

Lancet Oncol. 2018 Jun;19(6):785-798. doi: 10.1016/S1470-2045(18)30242-0. Epub 2018 May 9.

3.

Brain cancer genomics and epigenomics.

Archer TC, Sengupta S, Pomeroy SL.

Handb Clin Neurol. 2018;148:785-797. doi: 10.1016/B978-0-444-64076-5.00050-8.

PMID:
29478614
4.

Medulloblastoma: Molecular Classification-Based Personal Therapeutics.

Archer TC, Mahoney EL, Pomeroy SL.

Neurotherapeutics. 2017 Apr;14(2):265-273. doi: 10.1007/s13311-017-0526-y. Review.

5.

OTX2 Activity at Distal Regulatory Elements Shapes the Chromatin Landscape of Group 3 Medulloblastoma.

Boulay G, Awad ME, Riggi N, Archer TC, Iyer S, Boonseng WE, Rossetti NE, Naigles B, Rengarajan S, Volorio A, Kim JC, Mesirov JP, Tamayo P, Pomeroy SL, Aryee MJ, Rivera MN.

Cancer Discov. 2017 Mar;7(3):288-301. doi: 10.1158/2159-8290.CD-16-0844. Epub 2017 Feb 17.

6.

SMARCB1-mediated SWI/SNF complex function is essential for enhancer regulation.

Wang X, Lee RS, Alver BH, Haswell JR, Wang S, Mieczkowski J, Drier Y, Gillespie SM, Archer TC, Wu JN, Tzvetkov EP, Troisi EC, Pomeroy SL, Biegel JA, Tolstorukov MY, Bernstein BE, Park PJ, Roberts CW.

Nat Genet. 2017 Feb;49(2):289-295. doi: 10.1038/ng.3746. Epub 2016 Dec 12.

7.

Systems Approaches to Cancer Biology.

Archer TC, Fertig EJ, Gosline SJ, Hafner M, Hughes SK, Joughin BA, Meyer AS, Piccolo SR, Shajahan-Haq AN.

Cancer Res. 2016 Dec 1;76(23):6774-6777. Epub 2016 Nov 18.

8.

DiSCoVERing Innovative Therapies for Rare Tumors: Combining Genetically Accurate Disease Models with In Silico Analysis to Identify Novel Therapeutic Targets.

Hanaford AR, Archer TC, Price A, Kahlert UD, Maciaczyk J, Nikkhah G, Kim JW, Ehrenberger T, Clemons PA, Dančík V, Seashore-Ludlow B, Viswanathan V, Stewart ML, Rees MG, Shamji A, Schreiber S, Fraenkel E, Pomeroy SL, Mesirov JP, Tamayo P, Eberhart CG, Raabe EH.

Clin Cancer Res. 2016 Aug 1;22(15):3903-14. doi: 10.1158/1078-0432.CCR-15-3011. Epub 2016 Mar 24.

9.

Defining the molecular landscape of ependymomas.

Archer TC, Pomeroy SL.

Cancer Cell. 2015 May 11;27(5):613-5. doi: 10.1016/j.ccell.2015.04.015.

10.

A developmental program drives aggressive embryonal brain tumors.

Archer TC, Pomeroy SL.

Nat Genet. 2014 Jan;46(1):2-3. doi: 10.1038/ng.2857.

PMID:
24370739
11.

α5-GABAA receptors negatively regulate MYC-amplified medulloblastoma growth.

Sengupta S, Weeraratne SD, Sun H, Phallen J, Rallapalli SK, Teider N, Kosaras B, Amani V, Pierre-Francois J, Tang Y, Nguyen B, Yu F, Schubert S, Balansay B, Mathios D, Lechpammer M, Archer TC, Tran P, Reimer RJ, Cook JM, Lim M, Jensen FE, Pomeroy SL, Cho YJ.

Acta Neuropathol. 2014 Apr;127(4):593-603. doi: 10.1007/s00401-013-1205-7. Epub 2013 Nov 7.

12.

Medulloblastoma biology in the post-genomic era.

Archer TC, Pomeroy SL.

Future Oncol. 2012 Dec;8(12):1597-604. doi: 10.2217/fon.12.151. Review.

13.

Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations.

Pugh TJ, Weeraratne SD, Archer TC, Pomeranz Krummel DA, Auclair D, Bochicchio J, Carneiro MO, Carter SL, Cibulskis K, Erlich RL, Greulich H, Lawrence MS, Lennon NJ, McKenna A, Meldrim J, Ramos AH, Ross MG, Russ C, Shefler E, Sivachenko A, Sogoloff B, Stojanov P, Tamayo P, Mesirov JP, Amani V, Teider N, Sengupta S, Francois JP, Northcott PA, Taylor MD, Yu F, Crabtree GR, Kautzman AG, Gabriel SB, Getz G, Jäger N, Jones DT, Lichter P, Pfister SM, Roberts TM, Meyerson M, Pomeroy SL, Cho YJ.

Nature. 2012 Aug 2;488(7409):106-10. doi: 10.1038/nature11329.

14.

Hedgehog-GLI pathway in medulloblastoma.

Archer TC, Weeraratne SD, Pomeroy SL.

J Clin Oncol. 2012 Jun 10;30(17):2154-6. doi: 10.1200/JCO.2011.41.1181. Epub 2012 Apr 16. No abstract available.

PMID:
22508821
15.

Posterior fossa ependymomas: a tale of two subtypes.

Archer TC, Pomeroy SL.

Cancer Cell. 2011 Aug 16;20(2):133-4. doi: 10.1016/j.ccr.2011.08.003.

16.

Interaction of Sox1, Sox2, Sox3 and Oct4 during primary neurogenesis.

Archer TC, Jin J, Casey ES.

Dev Biol. 2011 Feb 15;350(2):429-40. doi: 10.1016/j.ydbio.2010.12.013. Epub 2010 Dec 11.

17.

Sox3 expression is maintained by FGF signaling and restricted to the neural plate by Vent proteins in the Xenopus embryo.

Rogers CD, Archer TC, Cunningham DD, Grammer TC, Casey EM.

Dev Biol. 2008 Jan 1;313(1):307-19. Epub 2007 Oct 24.

18.

Problems of handicapped children in military communities overseas: general considerations.

Archer TC.

Proc R Soc Med. 1969 Jul 7;62(7):646-9. No abstract available.

19.

A note on the use of daraprim as a malaria prophylactic in Nigerian troops and their families.

ARCHER TC.

J R Army Med Corps. 1960 Oct;106:182-5. No abstract available.

PMID:
13684036
20.

Civil affairs; Port Said; 1956.

ARCHER TC.

J R Army Med Corps. 1958 Apr;104(2):81-6. No abstract available.

PMID:
13526138
21.

Medical problems of the operational infantry soldier in Malaya.

ARCHER TC.

J R Army Med Corps. 1958 Jan;104(1):1-13. No abstract available.

PMID:
13502878
22.

An epidemic of infective hepatitis apparently due to a water-borne agent.

ARCHER TC.

J R Army Med Corps. 1954 Jul;100(3):161-79. No abstract available.

PMID:
13184510

Supplemental Content

Loading ...
Support Center